Literature DB >> 24293126

A novel mouse model for Down syndrome that harbor a single copy of human artificial chromosome (HAC) carrying a limited number of genes from human chromosome 21.

Kenichi Miyamoto1, Nobutaka Suzuki, Kosuke Sakai, Shuichi Asakawa, Tsuneko Okazaki, Jun Kudoh, Masashi Ikeno, Nobuyoshi Shimizu.   

Abstract

Down syndrome (DS), also known as Trisomy 21, is the most common chromosome aneuploidy in live-born children and displays a complicated symptom. To date, several kinds of mouse models have been generated to understand the molecular pathology of DS, yet the gene dosage effects and gene(s)-phenotype(s) correlation are not well understood. In this study, we established a novel method to generate a partial trisomy mice using the mouse ES cells that harbor a single copy of human artificial chromosome (HAC), into which a small human DNA segment containing human chromosome 21 genes cloned in a bacterial artificial chromosome (BAC) was recombined. The produced mice were found to maintain the HAC carrying human genes as a mini-chromosome, hence termed as a Trans-Mini-Chromosomal (TMC) mouse, and HAC was transmitted for more than twenty generations independent from endogenous mouse chromosomes. The three human transgenes including cystathionine β-synthase, U2 auxiliary factor and crystalline alpha A were expressed in several mouse tissues with various expression levels relative to mouse endogenous genes. The novel system is applicable to any of human and/or mouse BAC clones. Thus, the TMC mouse carrying a HAC with a limited number of genes would provide a novel tool for studying gene dosage effects involved in the DS molecular pathogenesis and the gene(s)-phenotype(s) correlation.

Entities:  

Mesh:

Year:  2013        PMID: 24293126     DOI: 10.1007/s11248-013-9772-x

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  43 in total

1.  Production of chimeras by aggregation of embryonic stem cells with diploid or tetraploid mouse embryos.

Authors:  Guy S Eakin; Anna-Katerina Hadjantonakis
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

2.  Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21.

Authors:  Robert Lyle; Frédérique Béna; Sarantis Gagos; Corinne Gehrig; Gipsy Lopez; Albert Schinzel; James Lespinasse; Armand Bottani; Sophie Dahoun; Laurence Taine; Martine Doco-Fenzy; Pascale Cornillet-Lefèbvre; Anna Pelet; Stanislas Lyonnet; Annick Toutain; Laurence Colleaux; Jürgen Horst; Ingo Kennerknecht; Nobuaki Wakamatsu; Maria Descartes; Judy C Franklin; Lina Florentin-Arar; Sophia Kitsiou; Emilie Aït Yahya-Graison; Maher Costantine; Pierre-Marie Sinet; Jean M Delabar; Stylianos E Antonarakis
Journal:  Eur J Hum Genet       Date:  2008-11-12       Impact factor: 4.246

3.  A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions.

Authors:  Tao Yu; Zhongyou Li; Zhengping Jia; Steven J Clapcote; Chunhong Liu; Shaomin Li; Suhail Asrar; Annie Pao; Rongqing Chen; Ni Fan; Sandra Carattini-Rivera; Allison R Bechard; Shoshana Spring; R Mark Henkelman; George Stoica; Sei-Ichi Matsui; Norma J Nowak; John C Roder; Chu Chen; Allan Bradley; Y Eugene Yu
Journal:  Hum Mol Genet       Date:  2010-05-04       Impact factor: 6.150

4.  Transcriptional regulation of the human cystathionine beta-synthase -1b basal promoter: synergistic transactivation by transcription factors NF-Y and Sp1/Sp3.

Authors:  Y Ge; M A Konrad; L H Matherly; J W Taub
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

5.  Human artificial chromosomes constructed using the bottom-up strategy are stably maintained in mitosis and efficiently transmissible to progeny mice.

Authors:  Nobutaka Suzuki; Kazuhiro Nishii; Tuneko Okazaki; Masashi Ikeno
Journal:  J Biol Chem       Date:  2006-07-12       Impact factor: 5.157

6.  The dominant role of Sp1 in regulating the cystathionine beta-synthase -1a and -1b promoters facilitates potential tissue-specific regulation by Kruppel-like factors.

Authors:  Kenneth N Maclean; Eva Kraus; Jan P Kraus
Journal:  J Biol Chem       Date:  2003-12-11       Impact factor: 5.157

Review 7.  Genetics of crystallins: cataract and beyond.

Authors:  Jochen Graw
Journal:  Exp Eye Res       Date:  2008-11-01       Impact factor: 3.467

8.  Cell to cell transfer of the chromatin-packaged human beta-globin gene cluster.

Authors:  Nobutaka Suzuki; Toshihide Itou; Yoshinori Hasegawa; Tsuneko Okazaki; Masashi Ikeno
Journal:  Nucleic Acids Res       Date:  2009-12-10       Impact factor: 16.971

9.  Species-specific transcription in mice carrying human chromosome 21.

Authors:  Michael D Wilson; Nuno L Barbosa-Morais; Dominic Schmidt; Caitlin M Conboy; Lesley Vanes; Victor L J Tybulewicz; Elizabeth M C Fisher; Simon Tavaré; Duncan T Odom
Journal:  Science       Date:  2008-09-11       Impact factor: 47.728

10.  Translating dosage compensation to trisomy 21.

Authors:  Jun Jiang; Yuanchun Jing; Gregory J Cost; Jen-Chieh Chiang; Heather J Kolpa; Allison M Cotton; Dawn M Carone; Benjamin R Carone; David A Shivak; Dmitry Y Guschin; Jocelynn R Pearl; Edward J Rebar; Meg Byron; Philip D Gregory; Carolyn J Brown; Fyodor D Urnov; Lisa L Hall; Jeanne B Lawrence
Journal:  Nature       Date:  2013-07-17       Impact factor: 49.962

View more
  8 in total

Review 1.  Combinations of chromosome transfer and genome editing for the development of cell/animal models of human disease and humanized animal models.

Authors:  Narumi Uno; Satoshi Abe; Mitsuo Oshimura; Yasuhiro Kazuki
Journal:  J Hum Genet       Date:  2017-11-27       Impact factor: 3.172

Review 2.  Pluripotent stem cell-based gene therapy approach: human de novo synthesized chromosomes.

Authors:  Sergey A Sinenko; Sergey V Ponomartsev; Alexey N Tomilin
Journal:  Cell Mol Life Sci       Date:  2020-10-03       Impact factor: 9.261

3.  Mouse embryonic stem cells with a multi-integrase mouse artificial chromosome for transchromosomic mouse generation.

Authors:  Yuki Yoshimura; Kazuomi Nakamura; Takeshi Endo; Naoyo Kajitani; Kanako Kazuki; Yasuhiro Kazuki; Hiroyuki Kugoh; Mitsuo Oshimura; Tetsuya Ohbayashi
Journal:  Transgenic Res       Date:  2015-06-09       Impact factor: 2.788

4.  Generation of a conditionally self-eliminating HAC gene delivery vector through incorporation of a tTAVP64 expression cassette.

Authors:  Artem V Kononenko; Nicholas C O Lee; Mikhail Liskovykh; Hiroshi Masumoto; William C Earnshaw; Vladimir Larionov; Natalay Kouprina
Journal:  Nucleic Acids Res       Date:  2015-02-20       Impact factor: 16.971

5.  Improving the efficiency of gene insertion in a human artificial chromosome vector and its transfer in human-induced pluripotent stem cells.

Authors:  Yoshinori Hasegawa; Masashi Ikeno; Nobutaka Suzuki; Manabu Nakayama; Osamu Ohara
Journal:  Biol Methods Protoc       Date:  2018-12-31

Review 6.  Meta-analysis of metabolites involved in bioenergetic pathways reveals a pseudohypoxic state in Down syndrome.

Authors:  Laszlo Pecze; Elisa B Randi; Csaba Szabo
Journal:  Mol Med       Date:  2020-11-09       Impact factor: 6.354

7.  Generating a transgenic mouse line stably expressing human MHC surface antigen from a HAC carrying multiple genomic BACs.

Authors:  Yoshinori Hasegawa; Tomoyuki Ishikura; Takanori Hasegawa; Takashi Watanabe; Junpei Suzuki; Manabu Nakayama; Yoshiaki Okamura; Tuneko Okazaki; Haruhiko Koseki; Osamu Ohara; Masashi Ikeno; Hiroshi Masumoto
Journal:  Chromosoma       Date:  2014-10-12       Impact factor: 4.316

8.  A novel system for simultaneous or sequential integration of multiple gene-loading vectors into a defined site of a human artificial chromosome.

Authors:  Teruhiko Suzuki; Yasuhiro Kazuki; Mitsuo Oshimura; Takahiko Hara
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.